Metoprolol mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Mechanism of Action: Beta-1 Selective Adrenergic Blockade
Metoprolol is primarily a beta-1 selective adrenergic receptor antagonist, often referred to as a cardioselective beta-blocker. This means it mainly blocks the beta-1 adrenergic receptors found in the heart, reducing the effects of adrenaline and noradrenaline on the heart muscle. As a result, metoprolol decreases heart rate, contractility, and cardiac output, which helps lower blood pressure and reduce the heart's oxygen demand. This is the main mechanism by which metoprolol is effective in treating conditions like hypertension, ischemic heart disease, and chronic heart failure Остроумова2015Åblad2009.
Cardiac Effects: Inhibition of Cardiac Stimulation
Metoprolol significantly inhibits the cardiac response to both externally administered and neuronally released noradrenaline. This action is responsible for its acute hemodynamic effects, such as lowering heart rate and blood pressure. Unlike some other beta-blockers, metoprolol has minimal effect on peripheral vasodilation and bronchial dilation at therapeutic doses, making it more selective for cardiac tissue .
Anti-Inflammatory and Infarct-Reducing Actions
Recent research has shown that metoprolol also has non-classical effects, particularly in the context of acute myocardial infarction. Metoprolol can reduce infarct size by targeting neutrophils, a type of white blood cell involved in inflammation. It inhibits neutrophil migration and their interaction with platelets, which helps reduce inflammation and tissue damage during heart attacks. This effect is dependent on beta-1 adrenergic receptor antagonism in the hematopoietic (blood cell-forming) compartment, not just in heart muscle cells García‐Prieto2017Clemente-Moragón2020. These anti-inflammatory actions are unique to metoprolol compared to other beta-blockers .
Cellular and Molecular Effects: Membrane Stabilization and Ion Channel Modulation
Metoprolol has a weak membrane-stabilizing effect, which may contribute to its ability to reduce pain from certain intravenous drugs and possibly to its antiarrhythmic properties . At the cellular level, metoprolol can shorten the action potential in heart muscle cells by blocking high-threshold calcium currents and modulating potassium currents. These effects help stabilize the electrical activity of the heart and may contribute to its protective effects against arrhythmias .
Modulation of Cardiac Hypertrophy and Inflammatory Signaling
Metoprolol can alleviate pathological cardiac hypertrophy (enlargement of heart muscle cells) by upregulating the AKT1–SERCA2 signaling pathway, which helps regulate calcium handling in heart cells. This action reduces abnormal calcium buildup and helps maintain normal heart function in the setting of stress or injury . Additionally, metoprolol can directly disrupt inflammatory signaling in human cardiomyocytes by modulating the NF-κB pathway and acting as a biased agonist for β-arrestin2, further contributing to its cardioprotective effects .
Additional Effects: Renal and Central Nervous System Actions
Metoprolol can increase urine output by enhancing renal blood flow and glomerular filtration rate, although this is not its primary clinical use . It also has mild effects on the central nervous system, which are related to its serum concentration, but these effects do not intensify at higher doses .
Conclusion
Metoprolol works mainly by selectively blocking beta-1 adrenergic receptors in the heart, reducing heart rate and contractility. It also has unique anti-inflammatory effects, can stabilize cardiac cell membranes, modulate ion channels, and influence signaling pathways involved in cardiac hypertrophy and inflammation. These combined actions make metoprolol effective for treating a range of cardiovascular conditions and provide additional protective benefits during acute cardiac events.
Sources and full results
Most relevant research papers on this topic